Home -> Law Blog Directory -> Qui Tam Blogs -> Pharma 101 - Pharmaceutical Fraud
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Qui Tam
: Pharma 101 - Pharmaceutical FraudWhistleblowers Needed to Expose Drug Manufacturing Deficiencies
By Nolan and Auerbach
ADVERTISEMENTS
Recently, we discussed GlaxoSmithKline?s False Claims Act settlement, in which the drug maker shelled out $750 million to quiet allegations about manufacturing deficiencies at its Puerto Rico. Based on a recently released FDA inspection report, it looks like another drug company?s Puerto Rican plant is having trouble following current Good Manufacturing Practices (cGMP).
In this report, the FDA rattles off a laundry list of violations at the plant owned by McNeil Consumer Healthcare, a unit of J read more
Full post as published by Pharma 101 - Pharmaceutical Fraud on December 21, 2010 (boomark / email).
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

FDA Seizes All Medical Products From N.J. Device Manufacturer for Significant Violations
Drug Maker Settles False Statement Suit
Children's Liquid Tylenol, Motrin, Zyrtec and Benadryl Recalled
FDA Bans Imports of 28 Indian-Made Drugs
Pfizer Hit With Huge Fine, Whistleblowers Reap Millions







